1. Home
  2. BLBD vs AGIO Comparison

BLBD vs AGIO Comparison

Compare BLBD & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Bird Corporation

BLBD

Blue Bird Corporation

HOLD

Current Price

$53.38

Market Cap

1.7B

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$27.85

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLBD
AGIO
Founded
1927
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
BLBD
AGIO
Price
$53.38
$27.85
Analyst Decision
Strong Buy
Buy
Analyst Count
5
8
Target Price
$67.20
$37.63
AVG Volume (30 Days)
392.7K
708.3K
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
22.78
N/A
EPS
0.94
N/A
Revenue
$1,480,099,000.00
$43,011,000.00
Revenue This Year
$6.07
$75.68
Revenue Next Year
$6.37
$167.63
P/E Ratio
$56.91
N/A
Revenue Growth
9.87
N/A
52 Week Low
$30.15
$22.24
52 Week High
$62.90
$46.00

Technical Indicators

Market Signals
Indicator
BLBD
AGIO
Relative Strength Index (RSI) 40.99 46.37
Support Level $49.55 $26.48
Resistance Level $58.25 $29.49
Average True Range (ATR) 2.03 1.13
MACD -0.95 -0.17
Stochastic Oscillator 10.05 25.09

Price Performance

Historical Comparison
BLBD
AGIO

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: